Sun Nelson bought AARD
February 14, 2025 · Form 4 insider transaction
Sun Nelson bought 7,001 shares of Aardvark Therapeutics, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,001
Price
N/A
Total value
N/A
InsiderSun Nelson
RoleOfficer
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateFebruary 14, 2025
Filing dateFebruary 19, 2025
Shares owned after89,484
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the "Issuer") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date.